Our app CancerMate, introducing the simulation for personalized oncology care for Triple-Negative Breast Cancer treated with Lynparza, has been given visibility in the “User Story Gallery” of the famous software for multiphysics simulation. Please click here to browse about.
Home of CancerMate: computational prognosis of neoadjuvant therapies for breast cancer